Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2011; 136(34/35): 1728-1732
DOI: 10.1055/s-0031-1286066
DOI: 10.1055/s-0031-1286066
Aktuelle Diagnostik und Therapie | Review article
Nephrologie, Endokrinologie
© Georg Thieme Verlag KG Stuttgart · New York
Praxisnaher Leitfaden zum Vorgehen bei Hyponatriämie
Practical approach to hyponatremiaFurther Information
Publication History
eingereicht: 8.3.2011
akzeptiert: 4.8.2011
Publication Date:
29 August 2011 (online)

Schlüsselwörter
Hyponatriämie - SIADH - Vasopressin-Rezeptor-Antagonist
Keywords
Hyponatremia - SIADH - Vasopressin receptor antagonist
Literatur
- 1 Asadollahi K, Beeching N, Gill G. Hyponatremia as a risk factor for hospital mortality. QJM. 2006; 99 877-80
- 2 Berl T, Quittnat-Pelletier F, Verbalis J G. et al . Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol. 2010; 21 705-712
- 3 Ellison D H, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007; 356 2064-2072
- 4 Fenske W, Maier S KG, Blechschmidt A et al. Utility and limitations oft the traditional diagnostic approach to hyponatremia. Am J Med. 2010; 123 652-657
- 5 Fenske W, Störk S, Koschker A-C. et al . Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab. 2008; 93 2991-2997
- 6 Gill G, Huda B, Boyd A. et al . Characteristics and mortality of severe hyponatraemia. Clin Endocrinol (Oxf). 2006; 65 246-249
- 7 Hannon M J, Thompson C J. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol. 2010; 162 Suppl 1 S5-12
- 8 Renneboog B, Musch W. Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits. Am J Med. 2006; 119 71.e1-8
- 9 Sandhu H S, Gilles E, DeVita M V et al. Hyponatremia is associated with large bone fracture in elderly patients. Int Urol Nephrol. 2009; 41 733-737
- 10 Schrier R W, Gross P, Gheorghiade M. et al . Tolvaptan, a selective oral vasopressin V2-receptor antagonist for hyponatremia. N Engl J Med. 2006; 355 2099-2112
- 11 Thompson C J, Crowley R K. Hyponatraemia. J R Coll Physicians Edinb. 2009; 39 154-157
- 12 Upadhyay A, Jaber B L, Madias N E. Incidence and prevalence of hyponatremia. Am J Med. 2006; 119 (Suppl 1) S30-35
- 13 Wald R, Jaber B, Price L et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010; 170 294-302
Prof. Dr. Peter Gross
Medizinische Klinik III Nephrologie
Universitätsklinikum
Dresden
Fetscherstr. 74
01307 Dresden
Email: peter.gross@uniklinikum-dresden.de